Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Nature Communications|March 11, 2018
MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like stateVittoria Poli, Luca Fagnocchi, Alessandra Fasciani, et al.Nature Communications|September 22, 2018
Author Correction: MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like stateVittoria Poli, Luca Fagnocchi, Alessandra Fasciani, et al.BJC Reports|March 24, 2026
Obesity-associated gene mutations across cancer types: a pan-cancer analysis of TCGA dataGaetana Porcelli, Rosario Nicola Brancaccio, Sebastiano Di Bella, et al.Frontiers in Immunology|November 30, 2023
EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomasAlice Turdo, Miriam Gaggianesi, Caterina D'Accardo, et al.Oncotarget|August 6, 2016
ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axisSimone Di Franco, Alice Turdo, Antonina Benfante, et al.Cell Death Discovery|April 26, 2025
Heightened IDO1 levels predict Bacillus Calmette-Guèrin failure in high-risk non-muscle-invasive bladder cancer patientsAlice Turdo, Gabriele Tulone, Sebastiano Di Bella, et al.Biomolecules|January 25, 2025
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal MelanomaMichele Massimino, Elena Tirrò, Stefania Stella, et al.Cancers|February 15, 2022
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem CellsMiriam Gaggianesi, Laura Rosa Mangiapane, Chiara Modica, et al.Cell Death and Differentiation|November 22, 2025
MAML1 drives Notch and Hedgehog oncogenic pathways by inhibiting Itch activity in triple-negative breast cancerSabrina Zema, Francesca Di Fazio, Maria Pelullo, et al.Oncogene|February 26, 2022
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51Alice Turdo, Miriam Gaggianesi, Simone Di Franco, et al.Pageof 4